Completion of radiopharmaceutical infrastructure by 2027
(Securing global competitiveness)
(Securing global competitiveness)
Production and supply of radio-isotopes
CellBion's Radioisotope Production Strategy Using Wolseong Reactor, Similar to Novartis' ITM Supply from CANDU Reactors in Canada
New Labeling Center – for Asia(Korea, Japan, China)
Completion of radiopharmaceutical infrastructure by 2027 (Securing global competitiveness)
